Description: The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Exchange: NYSE ARCA
Country: US
Currency: US Dollar ($)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 63.86 | 0.00 | 63.86 |
| Stock non-US | 35.90 | 0.00 | 35.90 |
| Cash | 0.23 | 0.00 | 0.23 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.57 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 64.01 | 92.60 |
| Europe Developed | 22.56 | 4.28 |
| Asia Emerging | 5.28 | 0.82 |
| Japan | 4.60 | 0.54 |
| Asia Developed | 3.55 | 0.00 |
| Australasia | 0.00 | 0.11 |
| United Kingdom | 0.00 | 1.65 |
| Africa/Middle East | 0.00 | 0.02 |